“Inhibiting Cathepsin S Activity with Variable New Antigen Receptors: A Novel Strategy”

https://pubmed.ncbi.nlm.nih.gov/38116078

Variable new antigen receptors (vNARs) show potential as a novel strategy to inhibit the activity of cathepsin S (CTSS), a protease implicated in various pathologies, by preventing its activation to the mature enzyme and impeding cell invasion.